Leadership Team
Matthew Lehman
Chief Operating Officer
Mr Lehman has a strong depth of experience in clinical research, development programs and obtaining drug approval. He has specific expertise in clinical development strategies, operations and in-outsourcing. Prior to joining Prima Biomed Mr Lehman was chief operating officer for SPRI Clinical Trials in Europe, where hemanaged an operations team of 60 staff and 50 consultants in all areas of clinical operations. Over the past nine years he has been involved in approximately 150 clinical programs in a variety of roles. In hisrole with Prima, he is be based in Zurich, Switzerland and plays a key role in leading the Company's research and development plans, and clinical trials for its CVacTM ovarian cancer therapy vaccine in Europe. Mr Lehman has a Master of Science from Columbia University in New York, and a Bachelor of Arts, Political Science and History from the University of Louisville, Kentucky, USA. He is also a member of the European Business Association and Association for Clinical Research Professionals.
Dr Neil Frazer
Chief Medical Officer
Dr Frazer has more than 23 years of drug development experience in multiple therapeutic areas, including more than six years of oncology drug development experience. Dr Frazer commenced his medical career as a UK-based anesthetist working in the UK National Health Service and has worked in Europe and in the US conducting Phase I-IV studies, which have led to product registrations in Europe and the US. Prior to joining Prima Biomed, Dr Frazer held senior management roles with Glaxo and Glaxo-Wellcome and Clintrials Research, and had also held executive medical roles with PharmaLinkFHI (eCRO), Shire Pharmaceuticals, Erimos Pharmaceuticals and Chimerix, Inc.
Ginny Raymond
Clinical Affairs Director
Ms Raymond is the clinical affairs director for Prima Biomed Limited. She was previously Pfizer's Director of Global Medical and has more than 20 years experience in clinical drug development with Pfizer, one of the world's leading pharmaceutical companies. In her time with Pfizer Ms Raymond was involved in the clinical development of more than 30 different generic compounds. In her role with Prima Biomed she is the Project Manager for the Company's US operations and is responsible for the execution of clinical trial work.
Vanessa Waddell
Business Development and Intellectual Property Manager
Ms Waddell is the Business Development Manager and Intellectual Property Manager of Prima BioMed Limited. Previous industry experience includes technical specialist and product development roles with AMRAD Biotech. Prior to joining Prima BioMed, Ms Waddell was employed in the commercialisation company of the Austin Research Institute. Since joining Prima BioMed, Ms Waddell has overseen project management of the company's first two investments, Cancer Vac Ltd and Arthron Ltd. In addition she has assisted in the identification, evaluation and structuring of two further investments made by the company. Ms Waddell has a BSc (Hons) degree in Science from the University of Sydney and a Masters of Business Administration from Deakin University.
Larisa Chisholm
Intellectual Property Manager
Ms Chisholm has an Honours degree at LaTrobe University (1992, studying the role of Natural Killer Cells in immune surveillance of cancer). From 1993 - 1996 she worked in the same laboratory and then joined the Immunogenetics and Xenotransplantation Laboratory at the then Austin Research Institute (Burnet). In 2001 she left to complete a Masters of Business Administration at La Trobe Universty. Ms Chisholm joined Prima Biomed in 2003 and her understanding of the Austin Research Centre and its people has proven invaluable. She has since worked in a variety of roles including market research, Grants Coordinator. Her current role is Intellectual Property Manager and she also assists with various business development activities.
|